MPD: Phenotype strain survey measures: chang

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Attie2:37	Attie2	body weight	high-fat high-sucrose diet	change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17	DO population		both	6-21wks	N=250	2018

Attie2:53	Attie2	body weight	high-fat high-sucrose diet	change in body weight after diet (compared to wk 10), wk 17 [g] bw_chg_wk17v10 110670	DO population		both	21wks	N=236	2018

Attie2:109	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726	DO population		both	19-26wks	N=240	2018

Attie2:110	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727	DO population		both	19-26wks	N=240	2018

Attie2:111	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728	DO population		both	19-26wks	N=240	2018

Attie2:112	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729	DO population		both	19-26wks	N=240	2018

Attie2:113	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730	DO population		both	19-26wks	N=240	2018

Attie2:114	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731	DO population		both	19-26wks	N=240	2018

Attie2:115	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732	DO population		both	19-26wks	N=240	2018

Attie2:116	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733	DO population		both	19-26wks	N=240	2018

Attie2:117	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734	DO population		both	19-26wks	N=240	2018

Bennett1:7	Bennett1	body weight	(none)	body weight change from 30 to 180 days (fold change) [ratio] bw_chg 36707	ILSXISS	43	f	25wks	N=4	2005

Bolivar4:4	Bolivar4	open field test	(none)	intrasession habituation for distance traveled (change in activity on day 1, 5 min bins) intrasession_hab 64704	inbred	14	m	8-12wks	N=18	2009

Bolivar4:8	Bolivar4	open field test	(none)	intersession habituation for distance traveled (change in activity over 3 days) intersession_hab 64708	inbred	14	m	8-12wks	N=18	2009

Boon1:11	Boon1	body weight	influenza A (H5N1) virus	change in body weight, post-infection [%] bw_change 46911 dosage group: low medium high	inbred	23	f	6-9wks	N=11	2011

Brinkmeyer1:145	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:147	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:149	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:151	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right	CC	4	both	4wks	N=1	2017

Cowell1:1	Cowell1	hormone quantification	Staphylococcus aureus	fold-change in serum IL-6 levels 24h post-infection compared to controls [ratio] IL6 49001	inbred	13	f	8wks	N=3	2012

Crabbe4:8	Crabbe4	grip strength	ethanol	change in peak force applied (T0-T30) post-injection, grip strength test [g] gripEtOHeffect 19108	inbred	21	both	7-12wks	N=6	2003

Crabbe4:9	Crabbe4	grip strength	ethanol	percent change in average latency to fall post-injection, grip strength test [%] pct_gripchange 19109	inbred	21	both	7-12wks	N=6	2003

Eumorphia6:10	Eumorphia6	echocardiography	(none)	cardiac aorta volume change [cm] aortic_dV_dt 29510	inbred	4	both	12wks	N=6	2008

Ferris1:2	Ferris1	body weight	influenza A (H1N1) virus	percent change in body weight, day 4 post-infection [%] bw_change 47602	CC pre w/par	163	f	8-16wks	N=1	2012

Golani1:3	Golani1	open field test	(none)	proportional change in activity in the 1st-half and 2nd-half sessions, 30 min test [ratio] DSTRD 10903	inbred	8	m	10wks	N=34	2003

Graham1:65	Graham1	RNA expression profiling	West Nile virus	virus in brain, fold change compared to matched control, post infection WNV_brain 63365 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:68	Graham1	RNA expression profiling	West Nile virus	virus in kidney, fold change compared to matched control, post infection WNV_kidney 63368 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:72	Graham1	RNA expression profiling	West Nile virus	virus in spleen, fold change compared to matched control, post infection WNV_spleen 63372 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:76	Graham1	RNA expression profiling	West Nile virus	Ifnb1 gene expression in brain, fold change compared to matched control, post infection Ifnb1_brain 63376 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:79	Graham1	RNA expression profiling	West Nile virus	Ifnb1 gene expression in kidney, fold change compared to matched control, post infection Ifnb1_kidney 63379 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:83	Graham1	RNA expression profiling	West Nile virus	Ifnb1 gene expression in spleen, fold change compared to matched control, post infection Ifnb1_spleen 63383 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:87	Graham1	RNA expression profiling	West Nile virus	Ifit1 gene expression in brain, fold change compared to matched control, post infection Ifit1_brain 63387 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:90	Graham1	RNA expression profiling	West Nile virus	Ifit1 gene expression in kidney, fold change compared to matched control, post infection Ifit1_kidney 63390 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:94	Graham1	RNA expression profiling	West Nile virus	Ifit1 gene expression in spleen, fold change compared to matched control, post infection Ifit1_spleen 63394 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Harrill2:5	Harrill2	body weight	DB289	fold change in body weight over testing period [ratio] bw_change 44105 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Hawes1:22	Hawes1	ophthalmoscopy	(none)	optic cup, changes [frequency rate] optic_cup 26722	inbred w/CC7	40	both	6-7wks	N=10	2008

Hunter1:6	Hunter1	histopathology	(none)	number of pulmonary metastases [n] mets 6006	MMTV PyVT transgenic	28	f		N=19	1998

Hunter1:7	Hunter1	histopathology	(none)	area of pulmonary metastases (x 10³) [µm²] met_area 6007	MMTV PyVT transgenic	28	f		N=14	1998

Hunter1:8	Hunter1	histopathology	(none)	total lung area (x 10³) [µm²] tot_area 6008	MMTV PyVT transgenic	28	f		N=14	1998

Hunter1:9	Hunter1	histopathology	(none)	number of pulmonary metastases per total lung area (x 10^-9) [n/µm²] ratio_mta 6009	MMTV PyVT transgenic	28	f		N=14	1998

Hunter1:10	Hunter1	histopathology	(none)	area of pulmonary metastases per number of metastases [µm²/n] met_size 6010	MMTV PyVT transgenic	28	f		N=14	1998

Hunter1:11	Hunter1	histopathology	(none)	area of pulmonary metastases per total lung area [ratio] ratio_ata 6011	MMTV PyVT transgenic	28	f		N=14	1998

Loos2:7	Loos2	home cage monitoring	(none)	habituation ratio describing change in cumulative activity duration, over 3 days of testing, log10 transformed [log(ratio)] activity_dur_hab 54007 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:22	Loos2	home cage monitoring	(none)	change in activity proportion: anticipation of phase change, over 3 days of testing activity_anticipation 54022 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:24	Loos2	home cage monitoring	(none)	change in activity proportion: response to phase onset, over 3 days of testing activity_response 54024 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:26	Loos2	home cage monitoring	(none)	change in Spout zone duration: anticipation of phase change, over 3 days of testing spout_anticipation 54026 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:28	Loos2	home cage monitoring	(none)	change in Spout zone duration: response to phase onset, over 3 days of testing spout_response 54028 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Loos2:32	Loos2	home cage monitoring	(none)	change in Feeding zone duration: anticipation of phase change, over 3 days of testing feeding_anticipation 54032 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:34	Loos2	home cage monitoring	(none)	change in Feeding zone duration: response to phase onset, over 3 days of testing feeding_response 54034 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Loos2:36	Loos2	home cage monitoring	(none)	change in OnShelter zone duration: anticipation of phase change, over 3 days of testing onshelter_anticipation 54036 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Loos2:38	Loos2	home cage monitoring	(none)	change in OnShelter zone duration: response to phase onset, over 3 days of testing onshelter_response 54038 dark light	inbred w/CC7	11	m	8-12wks	N=36	2016

Maurer1:66	Maurer1	body weight	atenolol, isoproterenol	fold change in body weight over testing period [ratio] bwchg 33266 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Mitchell1:17	Mitchell1	monitoring system	(none)	change in locomotor activity, day2 minus day1 [cm] habituation 37617	inbred	15	m	5-7wks	N=6	2010

Morgan1:13	Morgan1	body weight	high-fat diet and olanzapine	percent change in body weight, age 10wks vs. 8wks [%] bwchg_10 52613 age 10wks: control treated	inbred w/CC8	9	f	10wks	N=4	2014

Morgan1:15	Morgan1	body weight	high-fat diet and olanzapine	percent change in body weight, age 12wks vs. 8wks [%] bwchg_12 52615 age 12wks: control treated	inbred w/CC8	9	f	12wks	N=4	2014

Morgan1:17	Morgan1	body weight	high-fat diet and olanzapine	percent change in body weight, age 14wks vs. 8wks [%] bwchg_14 52617 age 14wks: control treated	inbred w/CC8	9	f	14wks	N=4	2014

Morgan1:19	Morgan1	body weight	high-fat diet and olanzapine	percent change in body weight, age 16wks vs. 8wks [%] bwchg_16 52619 age 16wks: control treated	inbred w/CC8	9	f	16wks	N=4	2014

Morgan1:21	Morgan1	body weight	high-fat diet and olanzapine	percent change in body weight, age 18wks vs. 8wks [%] bwchg_18 52621 age 18wks: control treated	inbred w/CC7	8	f	18wks	N=4	2014

Neuner1:72	Neuner1	fear conditioning test	(none)	change in percentage of time spent freezing from 1st post-shock to 4th post-shock (slope), day 1 contextual fear acquisition cfa_change 65972 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=3	2019

Palmer2:4	Palmer2	open field test	methamphetamine	change in activity from day 1 to day 2, habituation [cm] habituation_OFT 30004	B6.A consomic w/par	21	both	7-16wks	N=14	2008

Palmer2:5	Palmer2	open field test	methamphetamine	change in activity after methamphetamine, day3-day1 [cm] methactivity1_OFT 30005	B6.A consomic w/par	21	both	7-16wks	N=13	2008

Palmer2:6	Palmer2	open field test	methamphetamine	change in activity after methamphetamine and habituation, day3-day2 [cm] methactivity2_OFT 30006	B6.A consomic w/par	21	both	7-16wks	N=13	2008

Rhodes1:11	Rhodes1	body weight	exercise	change in body weight [ratio] BW_chg 34611 control with running wheel	inbred	12	both	15wks	N=4	2010

Richfield1:12	Richfield1	open field test	(none)	long-term habituation, change in horizontal activity over days 1-3 [n/d] horiz_long_habit 14512	inbred	15	m	7-9wks	N=11	2003

Richfield1:13	Richfield1	open field test	(none)	short-term habituation, change in horizontal activity over 45min, day 3 [n/min] horiz_short_habit 14513	inbred	15	m	7-9wks	N=11	2003

Richfield1:16	Richfield1	open field test	(none)	long-term habituation, change in ambulatory activity over days 1-3 [n/d] amb_long_habit 14516	inbred	15	m	7-9wks	N=11	2003

Richfield1:17	Richfield1	open field test	(none)	short-term habituation, change in ambulatory activity over 45 min, day 3 [n/min] amb_short_habit 14517	inbred	15	m	7-9wks	N=11	2003

Richfield1:20	Richfield1	open field test	(none)	long-term habituation, change in vertical activity over days 1-3 [n/d] vert_long_habit 14520	inbred	15	m	7-9wks	N=7	2003

Richfield1:21	Richfield1	open field test	(none)	short-term habituation, change in vertical activity over 45 min, day 3 [n/min] vert_short_habit 14521	inbred	15	m	7-9wks	N=7	2003

Schoenrock1:10	Schoenrock1	body weight	various diets	body weight change (start of testing minus weaning) [g] bw_chg 61210 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet	CC RIX	18	f	8-9wks	N=11	2018

Schoenrock1:62	Schoenrock1	body temperature	various diets	change in temperature (stress minus basal) [°C] SIH_temp_chg 61262 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet	CC RIX	18	f	8-9wks	N=11	2018

Schoenrock1:82	Schoenrock1	hormone quantification	various diets	change in serum corticosterone (stress minus basal) [ng/mL] CORT_chg 61282 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet	CC RIX	18	f	8-9wks	N=11	2018

Trullas1:53	Trullas1	hormone quantification	(none)	fold change across cohorts in corticosterone levels (plasma) (stress to basal ratio) [ratio] cortico_ratio 52853	inbred	5	m	6-8wks	N=3	1993

Attie2

body weight

high-fat high-sucrose diet

change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

DO population

both

6-21wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

change in body weight after diet (compared to wk 10), wk 17 [g] bw_chg_wk17v10 110670

DO population

both

21wks

N=236

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734

DO population

both

19-26wks

N=240

2018

Bennett1

body weight

(none)

body weight change from 30 to 180 days (fold change) [ratio] bw_chg 36707

ILSXISS

43

f

25wks

N=4

2005

Bolivar4

open field test

(none)

intrasession habituation for distance traveled (change in activity on day 1, 5 min bins) intrasession_hab 64704

inbred

14

m

8-12wks

N=18

2009

Bolivar4

open field test

(none)

intersession habituation for distance traveled (change in activity over 3 days) intersession_hab 64708

inbred

14

m

8-12wks

N=18

2009

Boon1

body weight

influenza A (H5N1) virus

change in body weight, post-infection [%] bw_change 46911 dosage group: low medium high

inbred

23

f

6-9wks

N=11

2011

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right

CC

4

both

4wks

N=1

2017

Cowell1

hormone quantification

Staphylococcus aureus

fold-change in serum IL-6 levels 24h post-infection compared to controls [ratio] IL6 49001

inbred

13

f

8wks

N=3

2012

Crabbe4

grip strength

ethanol

change in peak force applied (T0-T30) post-injection, grip strength test [g] gripEtOHeffect 19108

inbred

21

both

7-12wks

N=6

2003

Crabbe4

grip strength

ethanol

percent change in average latency to fall post-injection, grip strength test [%] pct_gripchange 19109

inbred

21

both

7-12wks

N=6

2003

Eumorphia6

echocardiography

(none)

cardiac aorta volume change [cm] aortic_dV_dt 29510

inbred

4

both

12wks

N=6

2008

Ferris1

body weight

influenza A (H1N1) virus

percent change in body weight, day 4 post-infection [%] bw_change 47602

CC pre w/par

163

f

8-16wks

N=1

2012

Golani1

open field test

(none)

proportional change in activity in the 1st-half and 2nd-half sessions, 30 min test [ratio] DSTRD 10903

inbred

8

m

10wks

N=34

2003

Graham1

RNA expression profiling

West Nile virus

virus in brain, fold change compared to matched control, post infection WNV_brain 63365 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

virus in kidney, fold change compared to matched control, post infection WNV_kidney 63368 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

virus in spleen, fold change compared to matched control, post infection WNV_spleen 63372 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifnb1 gene expression in brain, fold change compared to matched control, post infection Ifnb1_brain 63376 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifnb1 gene expression in kidney, fold change compared to matched control, post infection Ifnb1_kidney 63379 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifnb1 gene expression in spleen, fold change compared to matched control, post infection Ifnb1_spleen 63383 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifit1 gene expression in brain, fold change compared to matched control, post infection Ifit1_brain 63387 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifit1 gene expression in kidney, fold change compared to matched control, post infection Ifit1_kidney 63390 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Graham1

RNA expression profiling

West Nile virus

Ifit1 gene expression in spleen, fold change compared to matched control, post infection Ifit1_spleen 63394 day 2 day 4 day 7 day 12

CC RIX

5

m

8-10wks

N=1

2015

Harrill2

body weight

DB289

fold change in body weight over testing period [ratio] bw_change 44105 control DB289 difference

inbred

34

f

6-8wks

N=5

2012

Hawes1

ophthalmoscopy

(none)

optic cup, changes [frequency rate] optic_cup 26722

inbred w/CC7

40

both

6-7wks

N=10

2008

Hunter1

histopathology

(none)

number of pulmonary metastases [n] mets 6006

MMTV PyVT transgenic

28

f

N=19

1998

Hunter1

histopathology

(none)

area of pulmonary metastases (x 10³) [µm²] met_area 6007

MMTV PyVT transgenic

28

f

N=14

1998

Hunter1

histopathology

(none)

total lung area (x 10³) [µm²] tot_area 6008

MMTV PyVT transgenic

28

f

N=14

1998

Hunter1

histopathology

(none)

number of pulmonary metastases per total lung area (x 10^-9) [n/µm²] ratio_mta 6009

MMTV PyVT transgenic

28

f

N=14

1998

Hunter1

histopathology

(none)

area of pulmonary metastases per number of metastases [µm²/n] met_size 6010

MMTV PyVT transgenic

28

f

N=14

1998

Hunter1

histopathology

(none)

area of pulmonary metastases per total lung area [ratio] ratio_ata 6011

MMTV PyVT transgenic

28

f

N=14

1998

Loos2

home cage monitoring

(none)

habituation ratio describing change in cumulative activity duration, over 3 days of testing, log10 transformed [log(ratio)] activity_dur_hab 54007 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in activity proportion: anticipation of phase change, over 3 days of testing activity_anticipation 54022 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in activity proportion: response to phase onset, over 3 days of testing activity_response 54024 dark light

inbred w/CC7

11

m

8-12wks

N=40

2016

Loos2

home cage monitoring

(none)

change in Spout zone duration: anticipation of phase change, over 3 days of testing spout_anticipation 54026 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in Spout zone duration: response to phase onset, over 3 days of testing spout_response 54028 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Loos2

home cage monitoring

(none)

change in Feeding zone duration: anticipation of phase change, over 3 days of testing feeding_anticipation 54032 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in Feeding zone duration: response to phase onset, over 3 days of testing feeding_response 54034 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Loos2

home cage monitoring

(none)

change in OnShelter zone duration: anticipation of phase change, over 3 days of testing onshelter_anticipation 54036 dark light

inbred w/CC7

11

m

8-12wks

N=35

2016

Loos2

home cage monitoring

(none)

change in OnShelter zone duration: response to phase onset, over 3 days of testing onshelter_response 54038 dark light

inbred w/CC7

11

m

8-12wks

N=36

2016

Maurer1

body weight

atenolol, isoproterenol

fold change in body weight over testing period [ratio] bwchg 33266 control atenolol 10mg isoprot 1mg isoprot 10mg

inbred

23

m

7-13wks

N=10

2009

Mitchell1

monitoring system

(none)

change in locomotor activity, day2 minus day1 [cm] habituation 37617

inbred

15

m

5-7wks

N=6

2010

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 10wks vs. 8wks [%] bwchg_10 52613 age 10wks: control treated

inbred w/CC8

9

f

10wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 12wks vs. 8wks [%] bwchg_12 52615 age 12wks: control treated

inbred w/CC8

9

f

12wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 14wks vs. 8wks [%] bwchg_14 52617 age 14wks: control treated

inbred w/CC8

9

f

14wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 16wks vs. 8wks [%] bwchg_16 52619 age 16wks: control treated

inbred w/CC8

9

f

16wks

N=4

2014

Morgan1

body weight

high-fat diet and olanzapine

percent change in body weight, age 18wks vs. 8wks [%] bwchg_18 52621 age 18wks: control treated

inbred w/CC7

8

f

18wks

N=4

2014

Neuner1

fear conditioning test

(none)

change in percentage of time spent freezing from 1st post-shock to 4th post-shock (slope), day 1 contextual fear acquisition cfa_change 65972 6 mo 14 mo

F1 AD-BXD

55

both

23-57wks

N=3

2019

Palmer2

open field test

methamphetamine

change in activity from day 1 to day 2, habituation [cm] habituation_OFT 30004

B6.A consomic w/par

21

both

7-16wks

N=14

2008

Palmer2

open field test

methamphetamine

change in activity after methamphetamine, day3-day1 [cm] methactivity1_OFT 30005

B6.A consomic w/par

21

both

7-16wks

N=13

2008

Palmer2

open field test

methamphetamine

change in activity after methamphetamine and habituation, day3-day2 [cm] methactivity2_OFT 30006

B6.A consomic w/par

21

both

7-16wks

N=13

2008

Rhodes1

body weight

exercise

change in body weight [ratio] BW_chg 34611 control with running wheel

inbred

12

both

15wks

N=4

2010

Richfield1

open field test

(none)

long-term habituation, change in horizontal activity over days 1-3 [n/d] horiz_long_habit 14512

inbred

15

m

7-9wks

N=11

2003

Richfield1

open field test

(none)

short-term habituation, change in horizontal activity over 45min, day 3 [n/min] horiz_short_habit 14513

inbred

15

m

7-9wks

N=11

2003

Richfield1

open field test

(none)

long-term habituation, change in ambulatory activity over days 1-3 [n/d] amb_long_habit 14516

inbred

15

m

7-9wks

N=11

2003

Richfield1

open field test

(none)

short-term habituation, change in ambulatory activity over 45 min, day 3 [n/min] amb_short_habit 14517

inbred

15

m

7-9wks

N=11

2003

Richfield1

open field test

(none)

long-term habituation, change in vertical activity over days 1-3 [n/d] vert_long_habit 14520

inbred

15

m

7-9wks

N=7

2003

Richfield1

open field test

(none)

short-term habituation, change in vertical activity over 45 min, day 3 [n/min] vert_short_habit 14521

inbred

15

m

7-9wks

N=7

2003

Schoenrock1

body weight

various diets

body weight change (start of testing minus weaning) [g] bw_chg 61210 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet

CC RIX

18

f

8-9wks

N=11

2018

Schoenrock1

body temperature

various diets

change in temperature (stress minus basal) [°C] SIH_temp_chg 61262 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet

CC RIX

18

f

8-9wks

N=11

2018

Schoenrock1

hormone quantification

various diets

change in serum corticosterone (stress minus basal) [ng/mL] CORT_chg 61282 standard diet protein-deficient diet methyl-enriched diet vitamin D-deficient diet

CC RIX

18

f

8-9wks

N=11

2018

Trullas1

hormone quantification

(none)

fold change across cohorts in corticosterone levels (plasma) (stress to basal ratio) [ratio] cortico_ratio 52853

inbred

5

m

6-8wks

N=3

1993

Filter Table Results